Drugs / OC-DC vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01312376 | Mar 2011 → Oct 2015 | fallopian tube cancer, ovarian carcinoma, primary peritoneal carcinoma | Abramson Cancer Center at Penn Medicine | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OC-DC vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01312376 ↗ |
| Modality | Vaccine | “OC-DC vaccine” NCT01312376 ↗ |
| Route | Other | “OC-DC intradermally” NCT01312376 ↗ |